Sodium‐glucose cotransporter 2 inhibitor plus pioglitazone vs pioglitazone alone in patients with diabetes mellitus: A systematic review and meta‐analysis of randomized controlled trials

AIMS: To evaluate the efficacy and safety of combined therapy with sodium‐glucose cotransporter 2 (SGLT‐2) inhibitors plus pioglitazone versus pioglitazone alone in type 2 diabetic patients. MATERIALS AND METHODS: Systematic literature searches were performed across PubMed, EMBASE, Cochrane Central...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Hung‐Wei, Wu, Yi‐Ling, Sue, Yuh‐Mou, Lee, Meng, Ovbiagele, Bruce
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354759/
https://www.ncbi.nlm.nih.gov/pubmed/30815577
http://dx.doi.org/10.1002/edm2.50

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354759/
https://www.ncbi.nlm.nih.gov/pubmed/30815577
http://dx.doi.org/10.1002/edm2.50

Ejemplares similares